You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in the presence of TAA

Article Text

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in the presence of TAA

https://doi.org/10.1136/jitc-2023-SITC2023.0348

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.